Medical Research

Electroacupuncture ST36 prevents postoperative intra-abdominal adhesions formation.

Kristen Sparrow • January 28, 2015

 
Golden Chinese Sage Statues
Ancient Wisdom Through the Ages

Fascinating study that shows electroacupuncture at St36 can reduce postoperative adhesions by anti-inflammatory cholinergic effects.   Sham acupuncture does not have the same effect.  Vagotomy reduces this effect.  So somehow St36 has vagal enhancing characteristics. This is a key point for me since vagal tone is, to a large extent, what I am measuring with Heart Rate Variability.
Given this previous post that showed the specificity of bee venom at St 36, I think this might affect the way I practice. (Don’t worry, not going to start giving bee venom, just more electro at St36.)
J Surg Res. 2014 Dec 31.

Electroacupuncture ST36 prevents postoperative intra-abdominal adhesions formation.

Du MH1, Luo HM2, Tian YJ3, Zhang LJ3, Zhao ZK3, Lv Y3, Xu RJ4, Hu S5

Abstract

BACKGROUND:

We have recently proved electroacupuncture (EA) ST36 exerted an anti-inflammatory effect in the early phase of intra-abdominal adhesion formation. Evidences indicate that the anti-inflammatory effect of EA ST36 involves a cholinergic anti-inflammatory pathway-dependent mechanism via the vagus nerve. However, the exact effects and accurate vagal modulation of acupuncture in prevention of postoperative intra-abdominal adhesion formation has not been thoroughly evaluated.

MATERIALS AND METHODS:

Sprague-Dawley rats subjected to abdominal adhesion lesions operation at the cecum and abdominal wall were randomly divided into six groups as follows: (a) EAN: EA non-channel acupoints; (b) EA: EA ST36 after abdominal lesions; (c) VGX/EA: vagotomy (VGX) after abdominal lesions, then EA ST36; (d) VGX/EAN: VGX after abdominal lesions, then EAN; (e) α-BGT/EA: intraperitoneal injection of α-bungarotoxin (α-BGT, an antagonist of α7 subunit of cholinergic nicotinic receptor) before EA ST36, and (f) α-BGT/EAN group: α-BGT injection before EAN. Seven days after abdominal surgical lesions, the levels of tumor necrosis factor-α (TNF-α) and vascular endothelial growth factor (VEGF) in the adhesive tissue were evaluated, macroscopic observation and histopathologic evaluation of adhesion formation and assessment of angiogenesis by immunohistochemical staining of platelet endothelial cell adhesion molecule-1 (CD31) were performed.

RESULTS:

EA ST36 reduced TNF-α and VEGF levels in adhesive tissue homogenates 7 d after surgery, whereas vagotomy or intraperitoneal injection of α-BGT before EA ST36 reversed its suppressive effects. EA at non-channel acupoints with or without vagotomy or intraperitoneal injection of α-BGT before EA had no suppressive effects on TNF-α and VEGF levels. EA ST36 alleviated the adhesion formation, with both of macroscopic and histopathologic adhesion scores significantly lower than those of the EAN group (1.56 ± 0.29 versus 3.00 ± 0.82, 1.35 ± 0.4 versus 3.91 ± 0.8, respectively, both P < 0.05). Compared with the EAN group, EA ST36 significantly decreased angiogenesis evidenced by reduced CD31 positive microvessel density in adhesive tissue.

CONCLUSIONS:

EA ST36 might reduce the postoperative local inflammatory response, attenuate the angiogenesis, and alleviate the adhesion formation partly via activating the cholinergic anti-inflammatory mechanism.